202 related articles for article (PubMed ID: 19073331)
21. Novel mutations in the senataxin DNA/RNA helicase domain in ataxia with oculomotor apraxia 2.
Fogel BL; Perlman S
Neurology; 2006 Dec; 67(11):2083-4. PubMed ID: 17159128
[No Abstract] [Full Text] [Related]
22. Child with ataxia telangiectasia developing acute myeloid leukemia.
Lin CH; Lin WC; Wang CH; Ho YJ; Chiang IP; Peng CT; Wu KH
J Clin Oncol; 2010 May; 28(14):e213-4. PubMed ID: 20308662
[No Abstract] [Full Text] [Related]
23. The ATM gene and ataxia telangiectasia.
Mavrou A; Tsangaris GT; Roma E; Kolialexi A
Anticancer Res; 2008; 28(1B):401-5. PubMed ID: 18383876
[TBL] [Abstract][Full Text] [Related]
24. Mutations in senataxin responsible for Quebec cluster of ataxia with neuropathy.
Duquette A; Roddier K; McNabb-Baltar J; Gosselin I; St-Denis A; Dicaire MJ; Loisel L; Labuda D; Marchand L; Mathieu J; Bouchard JP; Brais B
Ann Neurol; 2005 Mar; 57(3):408-14. PubMed ID: 15732101
[TBL] [Abstract][Full Text] [Related]
25. Frequency and phenotypic spectrum of ataxia with oculomotor apraxia 2: a clinical and genetic study in 18 patients.
Le Ber I; Bouslam N; Rivaud-Péchoux S; Guimarães J; Benomar A; Chamayou C; Goizet C; Moreira MC; Klur S; Yahyaoui M; Agid Y; Koenig M; Stevanin G; Brice A; Dürr A
Brain; 2004 Apr; 127(Pt 4):759-67. PubMed ID: 14736755
[TBL] [Abstract][Full Text] [Related]
26. Senataxin, defective in ataxia oculomotor apraxia type 2, is involved in the defense against oxidative DNA damage.
Suraweera A; Becherel OJ; Chen P; Rundle N; Woods R; Nakamura J; Gatei M; Criscuolo C; Filla A; Chessa L; Fusser M; Epe B; Gueven N; Lavin MF
J Cell Biol; 2007 Jun; 177(6):969-79. PubMed ID: 17562789
[TBL] [Abstract][Full Text] [Related]
27. Complete deletion of the aprataxin gene: ataxia with oculomotor apraxia type 1 with severe phenotype and cognitive deficit.
Yoon G; Westmacott R; MacMillan L; Quercia N; Koutsou P; Georghiou A; Christodoulou K; Banwell B
J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):234-6. PubMed ID: 18202221
[No Abstract] [Full Text] [Related]
28. Ophthalmic features of ataxia telangiectasia-like disorder.
Khan AO; Oystreck DT; Koenig M; Salih MA
J AAPOS; 2008 Apr; 12(2):186-9. PubMed ID: 18083591
[TBL] [Abstract][Full Text] [Related]
29. Clinical and molecular characterization of ataxia with oculomotor apraxia patients in Saudi Arabia.
Bohlega SA; Shinwari JM; Al Sharif LJ; Khalil DS; Alkhairallah TS; Al Tassan NA
BMC Med Genet; 2011 Feb; 12():27. PubMed ID: 21324166
[TBL] [Abstract][Full Text] [Related]
30. Ataxia-oculomotor apraxia syndrome.
Gascon GG; Abdo N; Sigut D; Hemidan A; Hannan MA
J Child Neurol; 1995 Mar; 10(2):118-22. PubMed ID: 7782601
[TBL] [Abstract][Full Text] [Related]
31. ATM and breast cancer susceptibility.
Ahmed M; Rahman N
Oncogene; 2006 Sep; 25(43):5906-11. PubMed ID: 16998505
[TBL] [Abstract][Full Text] [Related]
32. A subgroup of spinocerebellar ataxias defective in DNA damage responses.
Gueven N; Chen P; Nakamura J; Becherel OJ; Kijas AW; Grattan-Smith P; Lavin MF
Neuroscience; 2007 Apr; 145(4):1418-25. PubMed ID: 17224243
[TBL] [Abstract][Full Text] [Related]
33. ATM gene founder haplotypes and associated mutations in Polish families with ataxia-telangiectasia.
Mitui M; Bernatowska E; Pietrucha B; Piotrowska-Jastrzebska J; Eng L; Nahas S; Teraoka S; Sholty G; Purayidom A; Concannon P; Gatti RA
Ann Hum Genet; 2005 Nov; 69(Pt 6):657-64. PubMed ID: 16266405
[TBL] [Abstract][Full Text] [Related]
34. A novel nonsense mutation in a Japanese family with ataxia with oculomotor apraxia type 2 (AOA2).
Nakamura K; Yoshida K; Makishita H; Kitamura E; Hashimoto S; Ikeda S
J Hum Genet; 2009 Dec; 54(12):746-8. PubMed ID: 19893583
[TBL] [Abstract][Full Text] [Related]
35. Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patients.
Anheim M; Monga B; Fleury M; Charles P; Barbot C; Salih M; Delaunoy JP; Fritsch M; Arning L; Synofzik M; Schöls L; Sequeiros J; Goizet C; Marelli C; Le Ber I; Koht J; Gazulla J; De Bleecker J; Mukhtar M; Drouot N; Ali-Pacha L; Benhassine T; Chbicheb M; M'Zahem A; Hamri A; Chabrol B; Pouget J; Murphy R; Watanabe M; Coutinho P; Tazir M; Durr A; Brice A; Tranchant C; Koenig M
Brain; 2009 Oct; 132(Pt 10):2688-98. PubMed ID: 19696032
[TBL] [Abstract][Full Text] [Related]
36. [Ataxia with oculomotor apraxia: clinical-genetic characteristics and DNA-diagnostic].
Rudenskaia GE; Kurkina MV; Zakharova EIu
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(10):58-63. PubMed ID: 23250602
[TBL] [Abstract][Full Text] [Related]
37. The ataxia-oculomotor apraxia 1 gene product has a role distinct from ATM and interacts with the DNA strand break repair proteins XRCC1 and XRCC4.
Clements PM; Breslin C; Deeks ED; Byrd PJ; Ju L; Bieganowski P; Brenner C; Moreira MC; Taylor AM; Caldecott KW
DNA Repair (Amst); 2004 Nov; 3(11):1493-502. PubMed ID: 15380105
[TBL] [Abstract][Full Text] [Related]
38. A novel mutation in the aprataxin (APTX) gene in an Iranian individual suffering early-onset ataxia with oculomotor apraxia type 1(AOA1) disease.
Nouri N; Nouri N; Aryani O; Kamalidehghan B; Sedghi M; Houshmand M
Iran Biomed J; 2012; 16(4):223-5. PubMed ID: 23183622
[TBL] [Abstract][Full Text] [Related]
39. [Research on clinical characteristics and ATM gene mutations in Chinese patients with ataxia-telangiectasia].
Jiang H; Tang BS; Hu ZM; Xia K; Xu B; Tang JG
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(16):1117-20. PubMed ID: 16029571
[TBL] [Abstract][Full Text] [Related]
40. [Ataxia-telangiectasia: a review].
Bott L; Thumerelle C; Cuvellier JC; Deschildre A; Vallée L; Sardet A
Arch Pediatr; 2006 Mar; 13(3):293-8. PubMed ID: 16423518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
